Biocorp - About the company
Biocorp is an acquired company based in Issoire (France), founded in 2004 by Jacques Gardette. It operates as a Developer and manufacturer of drug delivery systems. The company has 80 active competitors, including 27 funded and 19 that have exited. Its top competitors include companies like Halozyme, TriSalus Life Sciences and RenovoRx.
Company Details
Developer and manufacturer of drug delivery systems. The pharmaceutical product is the Newguard Passive Safety System which is compatible with various sizes of stacked needles PFS; This solution claims to generate benefits for pharmaceutical companies in terms of the supply chain, TCO, and packaging. The medical devices are connected with wireless technology. The medical devices are a smartpen injector (DataPen), smart sensors for the pen injector (EasyLog), and smarts sensors for inhalers (InsPair). The manufacturing services include injection molding, assembly, and packaging.
- Website
- biocorpsys.com
- Email ID
- *****@biocorpsys.com
- Phone Number
- +33 **********
Key Metrics
Founded Year
2004
Location
Issoire, France
Stage
Acquired
Ranked
41st among 80 active competitors
Employee Count
143 as on Sep 30, 2026
Exit Details
Acquired by New Nordic (Jun 05, 2023)
Biocorp's acquisition details
Biocorp got acquired by New Nordic on Jun 05, 2023 at an acquisition amount of $*****.
Click here to take a look at Biocorp's acquisition in detail
Sign up to download Biocorp's company profile
Biocorp's funding and investors
Biocorp has not raised any funding rounds yet.
Biocorp's founders and board of directors
Founder? Claim ProfileThe founders of Biocorp is Jacques Gardette.
Here are the details of Biocorp's key team members:
- Jacques Gardette: Founder & CEO of Biocorp. They are also an angel investor in 1 startup.
View details of Biocorp's Founder profiles and Board Members
Biocorp's employee count trend
Biocorp has 143 employees as of Sep 26. Here is Biocorp's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biocorp's Competitors and alternates
Top competitors of Biocorp include Halozyme, TriSalus Life Sciences and RenovoRx. Here is the list of Top 10 competitors of Biocorp, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Halozyme 1999, San Diego (United States), Public | Developer of drug delivery technologies for the treatment of various diseases | - | 67/100 | |
2nd | TriSalus Life Sciences 2009, Westminster (United States), Public | Developer of drug delivery devices to treat cancers | $83.4M | 66/100 | |
3rd | RenovoRx 2009, Los Altos (United States), Public | Developer of endovascular catheters for targeted delivery of IV fluids to peripheral organs | $10.9M | 62/100 | |
4th | Foresee Pharmaceuticals 2011, Taipei (Taiwan), Public | Developer of injectables and NCEs for cancer and chronic diseases | $32.5M | 59/100 | |
5th | Lyra Therapeutics 2005, Watertown (United States), Public | Biotechnology firm innovating localized therapies for chronic rhinosinusitis (CRS) | $110M | 58/100 | |
6th | Genprex 2009, Austin (United States), Public | Developer of therapeutics to treat cancer at molecular level | $3.11M | 56/100 | |
7th | Developer of a portfolio of long-acting injectables in various therapeutic areas | - | 55/100 | ||
8th | Cellectar Biosciences 2002, Florham Park (United States), Acquired | Developer of phospholipid drug conjugates (PDC) to treat cancer | - | 54/100 | |
9th | Milestone Scientific 1989, Livingston (United States), Public | Developer of computerized drug delivery injection system for dental and medical purposes | - | 50/100 | |
10th | AOP Health 1996, Vienna (Austria), Unfunded | Developer of treatments for rare diseases | - | - | 50/100 |
41st | Developer and manufacturer of drug delivery systems | - | - | 34/100 |
Looking for more details on Biocorp's competitors? Click here to see the top ones
Biocorp's Investments and acquisitions
Biocorp has made no investments or acquisitions yet.
Reports related to Biocorp
Here is the latest report on Biocorp's sector:
News related to Biocorp
•
Novo Nordisk to Acquire a Controlling Stake in BICORP for €154MG-MedTech•Mar 28, 2025•New Nordic, Biocorp
•
•
ASLI completes 28,500 sqm long-term lease renewal in AvignonProperty Magazine•May 03, 2023•Eurologisticsincome.Co.UK, Biocorp
•
Health2Sync Partners with Novo Nordisk and Biocorp in Japan to Integrate Mallya®︎ CapPR Newswire•Mar 28, 2023•New Nordic, Health2Sync, Biocorp, my-mallya.com
•
BIOCORP Announces Its Certification to the New European Medical Device RegulationACROFAN•Dec 19, 2022•Biocorp
•
•
BIOCORP and NOVO NORDISK strengthen their partnership with a new agreement on the Mallya® connected deviceBusiness Wire•Oct 26, 2022•Biocorp, New Nordic, biocorp.fr
•
BD, BIOCORP Sign Agreement for Connectivity and Traceability of Self-administered Injectable DrugsBusiness Wire•Oct 18, 2022•BD, Biocorp
•
BIOCORP and Merck KGaA, Darmstadt, Germany sign new partnership for intelligent drug deliveryBusiness Wire•Oct 10, 2022•Biocorp, Merck, Merck KGaA
•
Merck KGaA, Darmstadt, Germany, Partners with CNote to Invest $20 Million in Under-resourced CommunitiesCNW•Oct 04, 2022•Merck, Merck KGaA, CNote, Biocorp and 2 others
Are you a Founder ?
FAQs about Biocorp
Explore our recently published companies
- StarX - China based, Unfunded company
- Prime Meridian - India based, 2012 founded, Unfunded company
- Al Lujain - United Arab Emirates based, 2009 founded, Unfunded company
- kids of the diaspora - Vienna based, Unfunded company
- Gunkel's Home Improvements - Unfunded company
- Fleschutz - Unfunded company